248 related articles for article (PubMed ID: 35331175)
1. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
[TBL] [Abstract][Full Text] [Related]
2. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract][Full Text] [Related]
3. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.
Zhu Y; Wang L; Nong Y; Liang Y; Huang Z; Zhu P; Zhang Q
Cancer Manag Res; 2021; 13():8865-8878. PubMed ID: 34858060
[TBL] [Abstract][Full Text] [Related]
4. UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer.
Chen H; Zhang J; Zhou H; Zhu Y; Liang Y; Zhu P; Zhang Q
Front Oncol; 2022; 12():934145. PubMed ID: 35965551
[TBL] [Abstract][Full Text] [Related]
5. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
6. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
7. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive serum lipidomic analyses reveal potential biomarkers for malignant breast cancer: A case-control study.
Cao B; Yang S; Yan L; Li N
Cancer Biomark; 2023; 37(4):289-297. PubMed ID: 37302027
[TBL] [Abstract][Full Text] [Related]
9. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
Liu T; Tan Z; Yu J; Peng F; Guo J; Meng W; Chen Y; Rao T; Liu Z; Peng J
Expert Rev Proteomics; 2020 Mar; 17(3):233-242. PubMed ID: 32306783
[No Abstract] [Full Text] [Related]
10. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
11. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
[TBL] [Abstract][Full Text] [Related]
12. Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome.
Gao Y; Li J; Fan S; Chen P; Huang M; Bi H
Front Endocrinol (Lausanne); 2022; 13():895116. PubMed ID: 35846297
[TBL] [Abstract][Full Text] [Related]
13. UPLC-MS/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma.
Wang Z; Guo X; Wang W; Gao L; Bao X; Feng M; Lian W; Zhu H; Xing B
J Clin Endocrinol Metab; 2021 Jan; 106(1):e273-e287. PubMed ID: 33031533
[TBL] [Abstract][Full Text] [Related]
14. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
16. Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics.
Merciai F; Musella S; Sommella E; Bertamino A; D'Ursi AM; Campiglia P
J Chromatogr A; 2022 Jun; 1673():463124. PubMed ID: 35567813
[TBL] [Abstract][Full Text] [Related]
17. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
18. HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's Disease.
Zhi Y; Sun Y; Jiao Y; Pan C; Wu Z; Liu C; Su J; Zhou J; Shang D; Niu J; Hua R; Yin P
Front Pharmacol; 2021; 12():754185. PubMed ID: 34880754
[No Abstract] [Full Text] [Related]
19. Lipidomics for Determining Giant Panda Responses in Serum and Feces Following Exposure to Different Amount of Bamboo Shoot Consumption: A First Step towards Lipidomic Atlas of Bamboo, Giant Panda Serum and Feces by Means of GC-MS and UHPLC-HRMS/MS.
Zhu C; Pan X; Li G; Li C; Wu D; Tang J; Huang Y; Zou L; Laghi L
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232846
[TBL] [Abstract][Full Text] [Related]
20. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
